PET with N-[11C]methyl-piperidin-4-yl propionate ([11C]PMP), a selective substrate for AChE [54], has shown a reduction in AChE activity in AD patients [17, 19, 20]. This evidence concerns the gene ACHE and Alzheimer disease.